* Tenet Healthcare Corp THC.N THC is expected to show a
fall
in quarterly revenue when it reports results on July 24 for the
period ending June 30 2024
* The Dallas Texas-based company is expected to report a
1.5% decrease in revenue to $5.003 billion from $5.08 billion a
year ago, according to the mean estimate from 16 analysts, based
on LSEG data.The company's guidance on April 30 2024, for the
period ended June 30, was for revenue between $4.90 billion and
$5.10 billion.
* LSEG's mean analyst estimate for Tenet Healthcare Corp is
for
earnings of $1.90 per share. The company's EPS guidance on April
30 2024, for the period ended June 30, was between $1.58 and
$1.98
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 19 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Tenet
Healthcare
Corp is $149.57, above its last closing price of $133.27.
The company's guidance on April 30 2024 for the period ended
June 30 was for Earnings before Interest, Taxes, Depreciation
and Amortization of between USD4.9 billion and USD885 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 1.49 1.60 3.22 Beat 125.7
Dec. 31 2024 1.67 1.60 2.68 Beat 67.3
Sep. 30 2023 1.23 1.20 1.44 Beat 20.4
Jun. 30 2023 1.29 1.25 1.44 Beat 15.3
Mar. 1.16 1.16 1.42 Beat 22.9
31 2023
Dec. 31 2022 1.26 1.23 1.96 Beat 59.7
Jan. 1 0001 1.26 1.22 1.44 Beat 18.1
Jan. 1 0001 0.73 0.79 1.50 Beat 89.2
This summary was machine generated July 22 at 14:22 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)